Completed PHASE2 INTERVENTIONAL 2-arm NCT01882556

Early Use of Botulinum Toxin in Spasticity Post Stroke. (EUBoSS)

Is it Clinically Effective to Treat Arm Flexor Spasticity, With Botulinum Toxin - Type A (BoNTA) and Physiotherapy, as Soon as Signs of Abnormal Muscle Activity Are Observed?

Sponsor: Keele University

Conditions Contracture Muscle Spasticity Stroke

Interventions Placebo onabotulinumtoxinA

Updated 5 times since 2017 Last updated: Nov 17, 2014 Started: Jan 31, 2012 Primary completion: May 31, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01882556, this PHASE2 trial focuses on Contracture and Muscle Spasticity and remains completed. Sponsored by Keele University, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Keele University
Sandwell & West Birmingham Hospitals NHS Trust
Stroke Research Network

Data source: Sandwell & West Birmingham Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United Kingdom